Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
AmLactin®, the #1 moisturizer brand recommended by dermatologists for rough, dry skin, is donning a fresh, new look while bringing dry skin sufferers the same effective, hard-working formulas. The makeover comes with a new family name: AmLactin® Alpha-Hydroxy Skin Care. The contemporary design graces white, pearlescent bottles and tubes complemented by a series of vibrant colors and a signature droplet to convey the line’s intensity and success at helping skin retain its moisture.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55256-amlactin-alpha-hydroxy-skin-care-moisturizer
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For North America
Dr. Danielle Marcoux from Canada
Camp Liberté – Summer camp for children with skin disorders
This one-week summer camp run by volunteer dermatologists and nurses enrolled children aged 7 to 12 with moderate-to-severe skin disorders, as well as their families, to bring them together for support, social interaction and to increase their confidence. All the activities aim to increase patients’ confidence and self-esteem, improve social skills, reduce stigma about their condition and improve adherence to treatment.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
October is National Bullying Prevention Month, providing a national spotlight on an important issue facing a reported one in five kids: bullying. PACER’s National Bullying Prevention Center, the preeminent bullying prevention charity in the nation, is on a mission to drive social change that ends bullying. The organization works to put important resources in the hands of parents, educators and students alike, working to ensure that bullying is no longer an accepted childhood rite of passage. Today PACER and Clarisonic®, the creator of the #1 most-recommended skin-cleansing device by U.S. dermatologists*, announce a new partnership and campaign designed to drive awareness and raise donations for PACER’s bullying prevention efforts. For every #CleanTheMean social post shared on Facebook or Instagram this year, Clarisonic will donate $1 to PACER’s National Bullying Prevention Center, up to $100,000.
To view the multimedia release go to:
https://www.multivu.com/players/English/8191651-clarisonic-pacer-stop-bullying-cleanthemean-campaign/
Many people suffer from eczema and various skin disorders that they don’t understand. The names for these skin disorders are numerous – eczema, psoriasis, dermatitis, hives, allergies, scales, and so on. Most standard medical treatments fail to cure or give lasting relief to some of these disorders. This makes it so frustrating for those with these diseases since even dermatologists and doctors find it difficult to find a cure for them.
